Chronological immunolocalization of sclerostin and FGF23 in the mouse metaphyseal trabecular and cortical bone
- 1 January 2017
- journal article
- research article
- Published by Biomedical Research Press in Biomedical Research
- Vol. 38 (4) , 257-267
Abstract
To assess the chronological participation of sclerostin and FGF23 in bone metabolism, this study tracked the immunolocalization of sclerostin and FGF23 in the metaphyses of murine long bones from embryonic day 18 (E18) through 1 day after birth, 1 week, 2 weeks, 4 weeks, 8 weeks, and 20 weeks of age. We have selected two regions in the metaphyseal trabeculae for assessing sclerostin and FGF23 localization: close to the chondro-osseous junction, i.e., bone modeling site even in the adult animals, and the trabecular region distant from the growth plate, where bone remodeling takes place. As a consequence, sclerostin-immunopositive osteocytes could not be observed in both close and distant trabecular regions early at the embryonic and young adult stages. However, osteocytes gradually started to express sclerostin in the distant region earlier than in the close region of the trabeculae. Immunoreactivity for FGF23 was observed mainly in osteoblasts in the early stages, but detectable in osteocytes in the later stages of growth in trabecular and cortical bones. Fgf23 was weakly expressed in the embryonic and neonatal stages, while the receptors, Fgfr1c and αKlotho were strongly expressed in femora. At the adult stages, Fgf23 expression became more intense while Fgfr1c and aKlotho were weakly expressed. These findings suggest that sclerostin is secreted by osteocytes in mature bone undergoing remodeling while FGF23 is synthesized by osteoblasts and osteocytes depending on the developmental/growth stage. In addition, it appears that FGF23 acts in an autocrine and paracrine fashion in fetal and neonatal bones.Keywords
This publication has 40 references indexed in Scilit:
- Morphological aspects of the biological function of the osteocytic lacunar canalicular system and of osteocyte‐derived factorsOral Science International, 2012
- Characterization of the Structural Features and Interactions of SclerostinJournal of Biological Chemistry, 2009
- In vivo genetic evidence for klotho‐dependent, fibroblast growth factor 23 (Fgf23) ‐mediated regulation of systemic phosphate homeostasisThe FASEB Journal, 2008
- α-Klotho: A Regulator That Integrates Calcium HomeostasisAmerican Journal of Nephrology, 2007
- Klotho converts canonical FGF receptor into a specific receptor for FGF23Nature, 2006
- Suppression of Aging in Mice by the Hormone KlothoScience, 2005
- Sclerostin is a delayed secreted product of osteocytes that inhibits bone formationThe FASEB Journal, 2005
- Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEXJournal of Biological Chemistry, 2003
- Tetracycline-based histological analysis of bone remodelingCalcified Tissue International, 1969
- MATHEMATICAL ELEMENTS OF LAMELLAB BONE REMODELINGPlastic and Reconstructive Surgery, 1964